Interventional Cardiology Devices Market to Reach US$ 46.72 BN by 2030

The global interventional cardiology devices market is estimated to grow at a CAGR of 9.4% from 2021 to 2030 and to reach valuation US$ 46.72 billion by 2030.

The global interventional cardiology devices market is estimated to grow at a CAGR of 9.4% from 2021 to 2030 and to reach valuation US$ 46.72 billion by 2030.

The interventional cardiology devices are utilized in the treatment of cardiovascular disorders. The interventional cardiology devices such as angioplasty stents, angioplasty balloons, hemodynamic flow alteration devices, plaque modification devices, angioplasty catheters, repair stent grafts, endovascular aneurysm, and inferior vena cava filters. The rising adoption of all these devices is driving the growth of the global interventional cardiology devices market over the projected period.

Get the sample copy of report@ https://www.precedenceresearch.com/sample/1475

The growing adoption of minimally invasive or noninvasive surgeries and operations is boosting the growth of the worldwide interventional cardiology devices market. The minimally invasive surgeries ensure less damage to the body during the surgeries. As a result, the interventional cardiology devices for such procedures are demanded on a large scale, which is projected to the market expansion. In addition, technological advancements are paving way for the growth of the global interventional cardiology devices market. The innovative and advanced type of interventional cardiology devices are used for the treatment of cardiovascular disorders. It entails less risk on the body, thus driving the interventional cardiology devices market growth.

Interventional Cardiology Devices Market Size 2020 to 2030.jpg

Moreover, the growing geriatric population is supporting the expansion of the global interventional cardiology devices market during the forecast period. It has been observed that old people are more vulnerable to various kind of diseases. As a result, this factor is contributing to the interventional cardiology devices market. Furthermore, the insurance companies are providing funds and insurance policies for the fulfilment of the need of people who want the treatment against certain type of diseases. This reduces the burden of finance from the people. Thus, this factor is creating lucrative opportunities for the growth of the global interventional cardiology devices market.

Report Scope

Details

Market Size in 2030

USD 46.72 Billion

Growth Rate from 2021 to 2030

CAGR of 9.4%

Base Year

2021

Forecast Period

2022 to 2030

Report Highlights:

  • Based on the product, the interventional cardiology stents segment dominated the global interventional cardiology devices market in 2020 with largest market share. The interventional cardiology stents are considered as one of the best options in the process of treatment. The hospitals are highly adopting interventional cardiology stents for the cardiological operations. In addition, the technological developments and innovation is also driving the demand for interventional cardiology stents in the market.
  • Europe is the largest segment for interventional cardiology devices market in terms of region. The growth of the interventional cardiology devices market in Europe region is attributed to the rising prevalence of cardiovascular disorders. Furthermore, the growing incidents of obesity is also driving the growth of the interventional cardiology devices market in the region.
  • North America region is the fastest growing region in the interventional cardiology devices market.North America interventional cardiology devices market is growing due to the factors such as rising government activities for new product development and existence of major market players.

Ask here for customization@ https://www.precedenceresearch.com/customization/1475

Future of Interventional Cardiology Devices Market

The growth of the global interventional cardiology devices market is due to the rising number of cases of cardiovascular disorders. The cardiovascular diseases are the most common cause of death around the world. The cardiovascular disorders claimed the lives of 17.9 million individuals worldwide in 2019, accounting for 32% of all deaths. The heart attacks and strokes were responsible for 85% of these deaths. Nowadays, the people of all the age group are suffering from cardiovascular disorders. The number is expected to grow at rapid pace in coming years. Thus, the rising prevalence of cardiovascular diseases is creating prospects for the growth of the global interventional cardiology devices market in the near future.

COVID-19 Impact Analysis:

  • The global interventional cardiology devices market saw a decline in the growth due to the COVID-19 pandemic.
  • Many of the hospitals and healthcare centers halted the surgical and operational procedures due to fear of transmission of COVID-19 virus.
  • The manufacturing units for the interventional cardiology devices were also halted during the coronavirus outbreak.
  • In addition, the patients were not visiting hospitals for the treatment of any kind of disorder, which also caused decline in the sales of interventional cardiology devices.

Key Developments in the Marketplace:

  • The Next Generation Evolut PRO+TAVR System from Medtronic was approved by the Food and Drug Administration in 2019 for the treatment and diagnostics of patients with symptomatic severe aortic stenosis.
  • The SYNERGY Everolimus Eluting Platinum Chromium Coronary Stent System obtained Food and Drug Administration approval in August 2020.
  • The MitraClip Heart Valve Repair Device, which treats mitral regurgitation was approved by the Food and Drug Administration in 2019.
  • Boston Scientific Corporation received Food and Drug Administration approval for its Ranger Paclitaxel Coated PTA Balloon Catheter, which is used in PTA treatments in October 2020.

Some of the prominent players in the global interventional cardiology devices market include:

  • Boston Scientific Corporation
  • Medtronic
  • Edward Lifesciences Corporation
  • Abbott
  • BIOTRONIK SE & Co. KG
  • iVascular
  • Terumo Corporation
  • B. BarunMelsungen
  • Biosensors International Group
  • Cardinal Health

Segments Covered in the Report

By Product

  • Angioplasty Balloons
  • Angioplasty Stents
  • Angioplasty Catheters
  • Endovascular Aneurysm Repair Stent Grafts
  • Inferior Vena Cava (IVC) Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Accessories

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • MEA
  • Rest of the World

Click Here to View Full Report Table of Contents

Buy this Research Report@ https://www.precedenceresearch.com/checkout/1475

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333